U.S. Surgeon General Jerome Adams, M.D., today issued a public health advisory urging Americans who misuse opioids, have an opioid use disorder or recent overdose, or know someone who does, to carry and know how to use naloxone – a drug that can be delivered via nasal mist or injection to temporarily suspend the effects of an overdose until emergency responders arrive. “Each day we lose 115 Americans to an opioid overdose – that’s one person every 12.5 minutes,” Adams said. “It is time to make sure more people have access to this lifesaving medication, because 77% of opioid overdose deaths occur outside of a medical setting and more than half occur at home.” Approved by the Food and Drug Administration, naloxone is covered by most health plans and may be available to the uninsured at low or no cost through local public health programs or retailer and manufacturer discounts, Adams said. “To manage opioid addiction and prevent future overdoses, increased naloxone availability must occur in conjunction with expanded access to evidence-based treatment for opioid use disorder,” he said. For more information on preventing opioid overdoses, visit www.surgeongeneral.gov/priorities/opioid-overdose-prevention.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services today released an updated tool for viewing and comparing opioid prescribing rates over time and across regions.
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic last week held a webinar on the work it will undertake over the…
Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
Senate Health, Education, Labor and Pensions Committee Chairman Lamar Alexander, R-Tenn., today convened a hearing on “Managing Pain During the Opioid Crisis”…
Headline
The Centers for Medicare…
Headline
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…